|
Enhancing T Cell Therapy of Cancer
|
2P01CA094237-06
|
$1,905,870
|
$266,822
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
1R01CA129377-01A1
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Localization and Function of iNKT Cells in Neuroblastoma
|
5R01CA116548-04
|
$228,165
|
$228,165
|
METELITSA, LEONID
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Enhancing Activity of Alkylating Agents in Neuroblastoma
|
5R01CA082830-07
|
$210,659
|
$210,659
|
REYNOLDS, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-09
|
$1,908,071
|
$1,908,071
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-15
|
$411,318
|
$411,318
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Virotherapy for Neuroblastoma Stem Cells
|
1R21CA133663-01A1
|
$168,750
|
$168,750
|
CRIPE, TIMOTHY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
|
5K08CA123100-03
|
$139,320
|
$139,320
|
ATTIYEH, EDWARD
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
2R01CA094194-06A1
|
$367,942
|
$367,942
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
|
1K08CA128925-01A1
|
$139,320
|
$139,320
|
Goldsmith, Kelly
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
1R01CA124709-01A2
|
$675,621
|
$675,621
|
MARIS, JOHN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
GENOMICS OF HUMAN NEUROBLASTOMA
|
5K08CA111733-04
|
$139,320
|
$139,320
|
Mosse, YAEL
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Gangliosides and the Biology of Human Neuroblastoma
|
5R01CA042361-17
|
$261,674
|
$209,339
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Complex ganglioside function in neuroblastoma
|
5R01CA106532-04
|
$247,903
|
$247,903
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Neural Progenitor Cells as Cancer Therapy Vectors
|
7R01CA113446-04
|
$341,584
|
$341,584
|
Aboody, Karen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$46,850
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$1,903
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$2,148
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
$75,705
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
1R01CA124644-01A2
|
$334,075
|
$334,075
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
1R01CA123490-01A2
|
$256,678
|
$64,170
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-38
|
$793,241
|
$7,932
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-25
|
$422,772
|
$12,683
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Phenotypic Plasticity in Human Neuroblastoma
|
5R01CA077593-07
|
$239,931
|
$239,931
|
ROSS, ROBERT
|
FORDHAM UNIVERSITY
|
|
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.
|
5R01CA123211-03
|
$267,492
|
$267,492
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA051008-16S5
|
$2,928,516
|
$58,570
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA051008-16S6
|
$115,010
|
$2,300
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA051008-16S7
|
$110,862
|
$2,217
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
mTOR Signaling in Tumor Cell Motility
|
5R01CA115414-03
|
$201,997
|
$40,399
|
Huang, Shile
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
|
5U10CA128567-02
|
$517,815
|
$5,178
|
MILLS, GLENN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-37
|
$2,844,058
|
$28,441
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS
|
5R37CA034992-26
|
$672,247
|
$134,449
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
7R01CA124982-02
|
$291,722
|
$291,722
|
DING, HAN-FEI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-05
|
$291,566
|
$291,566
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
|
4R44CA130394-02
|
$485,175
|
$242,588
|
Kronauge, James
|
MOLECULAR INSIGHT PHARMACEUTICALS, INC.
|
|
Children's Oncology Group Statistics and Data Center Grant
|
2U10CA098413-06
|
$5,717,149
|
$228,686
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Community Clinical Oncology program Research Base
|
5U10CA095861-07
|
$1,984,870
|
$59,546
|
POLLOCK, BRAD
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
2U10CA098543-06
|
$31,493,718
|
$1,259,749
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S1
|
|
$0
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S2
|
$18,805
|
$752
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-06S3
|
$750,000
|
$30,000
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-04
|
$993,896
|
$198,779
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Swedish childhood cancers study
|
Z01 CP010183-00550
|
$2,170
|
$1,085
|
Anderson, William
|
DCEG (NCI)
|
|
Clinical Pharmacology of Anticancer Drugs
|
Z01 BC 011080
|
$936,285
|
$93,629
|
Balis, Frank
|
CCR (NCI)
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
Z01 BC 010006
|
$441,933
|
$22,097
|
Daar, Ira
|
CCR (NCI)
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
Z01 BC 010958
|
$441,933
|
$132,580
|
Daar, Ira
|
CCR (NCI)
|
|
Determinants of Melanocyte Transformation and Melanoma Progression
|
Z01 BC 010565
|
$300,493
|
$15,025
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
Z01 BC 010592
|
$40,782
|
$40,782
|
Khan, Javed
|
CCR (NCI)
|
Total relevant funding to Neuroblastoma for this search: $18,652,247
|